Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use

Clinical Lung Cancer · Published 2025-12-02 · DOI 10.1016/j.cllc.2025.11.018

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.cllc.2025.11.018

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC · Clinical Lung Cancer · 2026 · Cites or is cited by this article · Same journal
• Real-World Safety and Effectiveness of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective European Multicentre Study · Clinical Lung Cancer · 2026 · Same journal
• Next-Generation Sequencing Completion and Timeliness Using a Reflex Testing Protocol for Patients with Stage II to IV Nonsquamous Non–Small Cell Lung Cancer · Clinical Lung Cancer · 2026 · Same journal
• Brief Report: A Pilot Study Evaluating the Feasibility, Safety, and Compliance With a Fasting-Mimicking Diet in Patients With Metastatic Non–Small Cell Lung Cancer · Clinical Lung Cancer · 2026 · Same journal
• Complete Spontaneous Regression of Lung Adenocarcinoma With No Residual Malignancy After Surgical Resection: A Case Report · Clinical Lung Cancer · 2026 · Same journal
• Clinicogenomic Predictors of First-line Immune Checkpoint Inhibitor Outcomes in Non–Small Cell Lung Cancer: A Nationwide C CAT Cohort From Japan · Clinical Lung Cancer · 2026 · Same journal
• Streamlining the Frequency, Conduct, and Location of Assessments in Registrational Lung Cancer Clinical Trials for Supplemental Applications: Recommendations of a LUNGevity Foundation Multistakeholder Working Group · Clinical Lung Cancer · 2026 · Same journal
• Impact of Programmed Death Ligand 1 Expression on Outcomes in Stage I-II Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinoma · Clinical Lung Cancer · 2026 · Same journal
• Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State · Clinical Lung Cancer · 2026 · Same journal
• Adjuvant Therapy After Pathologic Complete Response to Neoadjuvant Immunochemotherapy in Non–Small Cell Lung Cancer: A Multicenter Retrospective Real-World Study · Clinical Lung Cancer · 2026 · Same journal